Zekun Peng
State Key Laboratory Of Cardiovascular Disease, Chinese Academy Of Medical Sciences And Peking Union Medical College, Xicheng District
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction to: Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.
Journal: Circulation research
Published: February 26, 2026
Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 26, 2024
Identification of the biological processes, immune cell landscape, and hub genes shared by acute anaphylaxis and ST-segment elevation myocardial infarction.
Journal: Frontiers in pharmacology
Published: April 24, 2023
Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.
Journal: Circulation research
Published: July 28, 2022
Stage-Dependent Impact of RIPK1 Inhibition on Atherogenesis: Dual Effects on Inflammation and Foam Cell Dynamics.
Journal: Frontiers in cardiovascular medicine
Published: May 26, 2021
Drug Discovery for Coronary Artery Disease.
Journal: Advances in experimental medicine and biology
Published: April 05, 2020
Endothelial Response to Pathophysiological Stress.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 24, 2019
The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice.
Journal: Journal of cellular and molecular medicine
Published: June 11, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026